Back
EHRA Premium Access

One-year results from the FLXibility post-approval study: final real-world clinical outcomes with a next-generation left atrial appendage closure device

Session: Moderated ePosters - How to optimise stroke prevention in atrial fibrillation
Topic: Left Atrial Appendage Closure
Speaker: Professor T. Betts (Oxford, GB)
Event: EHRA 2022

Congress Presentation

About the speaker

Professor Timothy Betts

Oxford University Hospitals NHS Trust, Oxford (United Kingdom of Great Britain & Northern Ireland)
9 presentations
0 follower

3 more presentations in this session

Impact of P-glycoprotein and/or CYP3A4-interacting drugs on the risk-benefit profile of NOACs in patients with atrial fibrillation: a meta-analysis

Speaker: Mr M. Grymonprez (Ghent, BE)

Access
Abstract
Slides
Thumbnail

Prevalence and outcomes of hypoattenuation defects and appendage patency on computed tomography after left atrial appendage closure

Speaker: Professor H. Cochet (Bordeaux, FR)

Access
Abstract
Slides
Thumbnail

Single versus dual antiplatelet therapy following transcatheter left atrial appendage closure

Speaker: Doctor A. Sabbag (Ramat Gan, IL)

Access
Abstract
Slides
Thumbnail

Access the full session

Moderated ePosters - How to optimise stroke prevention in atrial fibrillation

Speakers: Professor T. Betts, Mr M. Grymonprez, Professor H. Cochet, Doctor A. Sabbag
Access
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb